tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
OBIO
Orchestra BioMed Holdings
RESEARCH TOOLSreports
Want to see OBIO full AI Analyst Report?

Orchestra BioMed Holdings (OBIO) Income Statement

101 Followers

Orchestra BioMed Holdings Income Statement

Last quarter (Q4 2025), Orchestra BioMed Holdings's total revenue was $30.92M, an increase of 3461.87% from the same quarter last year. In Q4, Orchestra BioMed Holdings's net income was $6.25M. See Orchestra BioMed Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 33.48M$ 2.64M$ 2.76M$ 3.53M$ -782.00K
Gross Profit
$ 33.29M$ 2.43M$ 2.57M$ 3.21M$ -981.00K
Operating Expenses
$ 85.10M$ 66.73M$ 54.08M$ 35.87M$ 20.82M
Depreciation and Amortization
$ 327.00K$ 308.00K$ 287.00K$ 222.00K$ 181.00K
EBITDA
$ -51.48M$ -63.99M$ -51.22M$ -32.44M$ -21.62M
Operating Income
$ -51.81M$ -64.30M$ -51.51M$ -32.66M$ -21.80M
Other Income/Expenses
$ -1.15M$ 3.28M$ 2.39M$ -951.00K$ -1.22M
Pretax Income
$ -52.95M$ -61.02M$ -49.12M$ -33.61M$ -23.01M
Net Income
$ -52.95M$ -61.02M$ -49.12M$ -33.61M$ -23.01M
Per Share Metrics
Basic EPS
$ -1.11$ -1.66$ -1.48$ -1.32$ -0.02
Diluted EPS
$ -1.11$ -1.66$ -1.48$ -1.32$ -0.02
Weighted Average Shares Outstanding
 38.39B 36.82M 33.23M 25.47M 20.45M
Weighted Average Shares Outstanding (Diluted)
 38.39B 36.82M 33.23M 25.47M 20.45M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History